ESHRE Ovarian Stimulation guideline update – additional stakeholder review for biosimilars section
Last year, ESHRE published the updated version of the Ovarian Stimulation for IVF/ICSI evidence-based guideline.
In light of newly available information, the guideline group decided to withdraw the section on follitropin alpha biosimilars, pending further consideration of evidence.
The guideline group has now finalised its revision, and is presenting the updated section for stakeholder review.
The updated follitropin alpha biosimilars section will be open for stakeholder comments between 18 May and 8 June.
How to participate:
- Read the draft section
- Download the reviewer form
- Send the completed reviewer form to guidelines@eshre.eu before 8 June.
On behalf of the Ovarian stimulation guideline group.